This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.
The obesity medicine field has gained a new entrant, with AbbVie licensing an ex...
Medicaid cuts could force disabled people out of the public sphere and into nurs...
Voting is now open for STAT Madness, our bracket-style competition in which read...
Boston Children's Hospital's Ken Mandl talks about the risk of commercial intere...
The science behind the “post-vaccination syndrome” study is dubious — but the ha...
Researchers lose access to crucial CDC data on maternal and infant health while ...
HHS is re-evaluating a nearly $600 million contract with Moderna to develop and ...
“With the right policies, advanced science, and strong leadership in government ...
Why the Trump administration’s messaging on the Texas measles outbreak strikes s...
In this edition of STAT's Health Tech newsletter: Google gets an FDA clearance, ...
The latest biotech updates, brought to you by The Readout newsletter.
Francis Collins, former longtime director of the National Institutes of Health, ...
CMS is facing employee firings, flagging morale, confusing messaging, and the sp...
A peer reviewer questioned the premise of our study into the potential impact of...
2025 bracket Welcome to STAT Madness, a bracket-style contest to find the best i...
HHS Secretary Robert F. Kennedy Jr. moved to rescind the longtime practice of gi...
HHS Secretary Robert F. Kennedy Jr. moved to rescind the longtime practice of gi...
The once high-flying Ginkgo Bioworks is further scaling back its Boston real est...
Pfizer made changes to its diversity, equity, and inclusion webpage, as companie...
Friday's biotech news includes Pfizer's shifting DEI focus and Eli Lilly's costl...
“With the right policies, advanced science, and strong leadership in government ...
I tested out Grok, my company’s diagnostic AI, and several others to see which w...